Product Information
CEVIMELINE HCL 30 MG CAPSULE is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.6871 per EA under NDC 00713093701. Its NADAC has been published 161 times since May 31, 2023.
The High Outlier badge above means this manufacturer's average price in the cevimeline hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713093701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEVIMELINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020989On Market Since
1/3/2023
Pharmacological Classes
Price Statistics
The NADAC for CEVIMELINE HCL 30 MG CAPSULE has been published 161 times since May 31, 2023, and over the history we have for it it has declined 44.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6871 per EA |
|---|---|
| All-time high | $1.2357 (Jun 14, 2023) |
| All-time low | $0.6268 (Nov 20, 2024) |
| 52-week high | $0.7172 |
| 52-week low | $0.6572 |
| Median price | $0.7451 |
| Average price | $0.8515 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 161 |
| Tracking since | May 31, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEVIMELINE HCL 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEVIMELINE HCL 30 MG CAPSULE, manufactured by Cosette Pharmaceuticals, Inc., is $0.6871 per EA (NDC 00713093701), effective Jun 24, 2026.
How has the price of CEVIMELINE HCL 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has declined 44.4%. It has been tracked across 161 weekly CMS publications since May 31, 2023.
What are the highest and lowest recorded NADAC prices for CEVIMELINE HCL 30 MG CAPSULE?
Since May 31, 2023, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has ranged from a low of $0.6268 (Nov 20, 2024) to a high of $1.2357 (Jun 14, 2023), with a median of $0.7451 per EA.
Are there cheaper alternatives to CEVIMELINE HCL 30 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CEVIMELINE HCL 30 MG CAPSULE, but none are currently priced below it.
Who manufactures CEVIMELINE HCL 30 MG CAPSULE?
CEVIMELINE HCL 30 MG CAPSULE (NDC 00713093701) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification